Shingles Vaccine Linked to Lower Dementia Risk in Multiple Studies
New studies suggest shingles vaccines may reduce dementia risk and slow biological aging, with Shingrix showing amplified protective effects.
Your source for expert insights into the future of healthcare. Factide delivers in-depth coverage of biotechnology, medical engineering, and the AI-driven innovations transforming global health outcomes with precision and speed.
New studies suggest shingles vaccines may reduce dementia risk and slow biological aging, with Shingrix showing amplified protective effects.
Men with Y chromosome loss in tumors face higher cancer risks in shared organs. New research explores LOY as a potential therapeutic target, though causality remains unproven.
A five-year study reveals U.S. mothers face prolonged postpartum depression linked to policy gaps in family support.
AI chatbots handle 230 million weekly health queries, but face challenges in translating medical jargon and securing patient data.
A racing heart or skipped beat may indicate arrhythmia. Learn about common types like PACs, PVCs, and AFib, along with treatments from vagal maneuvers to ablation. Consult a healthcare professional for evaluation.
Policy intent vs reality: low hospital compliance, mixed price effects, and limited patient use of healthcare price transparency data.
Heart disease remains the top U.S. killer, but lifestyle changes and coronary calcium scoring can catch silent plaque early.
New fluorescent method enables real-time tracking of microplastics in biological systems, advancing toxicity research.
Researchers transformed sunflower oil by-products into high-protein, antioxidant-rich bread, improving texture with aqueous extract. Study funded by FAPESP.
AI chatbot misuse has been named the top health technology hazard for 2026. Experts warn that relying on AI tools for medical advice may lead to misdiagnosis, delayed treatment, and serious patient safety risks.
Death Clock's Life Lab uses AI and blood biomarkers to predict mortality and create personalized longevity plans. Learn about its $99–$299 service targeting heart disease, cancer, diabetes, and dementia.
The autologous cell therapy market is projected to grow from $10.6 billion in 2023 to $44.55 billion by 2033, driven by CAR-T therapies and regenerative medicine.